| |
| |
|
| Insider
Information: |
Verratti Mark |
| Relationship: |
Chief Commercial Officer |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
298,715 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,709,139 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
298,715 |
|
|
| Total
Value |
$6,709,139 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
5
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 0.6%
|
 -109.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Commercial Officer |
2024-04-14 |
298,715 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-08-25 |
4 |
D |
$24.89 |
$25,662 |
D/D |
(1,031) |
242,176 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-09-21 |
4 |
D |
$20.20 |
$14,180 |
D/D |
(702) |
241,474 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-09-25 |
4 |
D |
$18.69 |
$52,201 |
D/D |
(2,793) |
238,681 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-09-26 |
4 |
D |
$18.41 |
$42,214 |
D/D |
(2,293) |
236,388 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2022-10-09 |
4 |
D |
$19.62 |
$164,141 |
D/D |
(8,366) |
228,022 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-03-22 |
4 |
D |
$22.91 |
$30,951 |
D/D |
(1,351) |
266,076 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-03-24 |
4 |
D |
$23.72 |
$63,309 |
D/D |
(2,669) |
263,407 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-04-14 |
4 |
D |
$22.27 |
$15,656 |
D/D |
(703) |
262,704 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-09-21 |
4 |
D |
$16.77 |
$18,045 |
D/D |
(1,076) |
261,628 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-09-26 |
4 |
D |
$15.99 |
$56,333 |
D/D |
(3,523) |
258,105 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2023-10-09 |
4 |
D |
$15.01 |
$125,574 |
D/D |
(8,366) |
249,739 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2024-03-15 |
4 |
D |
$21.16 |
$77,996 |
D/D |
(3,686) |
304,684 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2024-03-22 |
4 |
D |
$22.24 |
$36,652 |
D/D |
(1,648) |
303,036 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2024-03-24 |
4 |
D |
$22.24 |
$72,169 |
D/D |
(3,245) |
299,791 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Commercial Officer |
• – – |
2024-04-14 |
4 |
D |
$19.55 |
$21,036 |
D/D |
(1,076) |
298,715 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President Assurex Health Inc.O |
• – – |
2017-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
41 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
